#ASH25:再生元淋巴瘤双特异性药物一扇门关闭,另一扇门开启
#ASH25: As one door closes for Regeneron’s lymphoma bispecific, another reopens
生物技术与制药领域的最新动态
#ASH25: As one door closes for Regeneron’s lymphoma bispecific, another reopens
Is Agilent Technologies, Inc.'s (NYSE:A) Recent Stock Performance Tethered To Its Strong Fundamentals? - Yahoo Finance
Vertex CRISPR therapy hits early goal in children with blood disorders
ASH 2025: Casgevy for kids? Expanding, improving SCD gene therapies
Mirabella Financial Services LLP Decreases Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Marshall Wace LLP Lowers Stake in Waters Corporation $WAT - MarketBeat
Apple Tree Partners scores legal win against alleged holdout Russian investor
ACIP vote, more FDA turnover; Introducing Endpoints Signal; ARCH, Parker Institute building next cancer bet; and more
How is Agilent Technologies' stock performance compared to other healthcare stocks? - MSN
Epoch Investment Partners Inc. Sells 53,867 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
First Trust Advisors LP Sells 22,018 Shares of Waters Corporation $WAT - MarketBeat
Illumina (ILMN): Assessing Valuation After a Quiet Share Price Rebound - Yahoo Finance
Illumina (ILMN): Assessing Valuation After a Quiet Share Price Rebound - Yahoo! Finance Canada
ORIC’s lung cancer pill shows promise in some settings but is dropped for HER2 mutations
Illumina (ILMN): Reassessing Valuation After Recent Share Price Momentum From a Low Base - simplywall.st
‘Market’s thinking is backwards’: FDA’s 1-trial approval plan would boost R&D spend, Jefferies says
FDA panel votes against J&J's novel shunt implant for heart failure
Michel Lagarde Sells 32,000 Shares of Thermo Fisher Scientific (NYSE:TMO) Stock - MarketBeat
RFK Jr.’s hand-picked panel questions childhood vaccine schedule
Lagarde of Thermo Fisher sells $12.4m in stock - Investing.com